perospirone has been researched along with Depression in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Morita, M; Nakayama, K | 1 |
| Hirayasu, Y; Karashima, A; Otsuka, T; Shioya, H; Sugiyama, N; Togo, T; Uehara, K; Yoshimi, A | 1 |
2 other study(ies) available for perospirone and Depression
| Article | Year |
|---|---|
Mirtazapine in combination with perospirone synergistically enhances dopamine release in the rat prefrontal cortex via 5-HT1A receptor activation.
Topics: Animals; Depression; Disease Models, Animal; Dopamine; Drug Resistance; Drug Synergism; Drug Therapy, Combination; Isoindoles; Male; Mianserin; Microdialysis; Mirtazapine; Piperazines; Prefrontal Cortex; Pyridines; Rats; Rats, Wistar; Serotonin; Serotonin 5-HT1 Receptor Agonists; Thiazoles | 2011 |
Perospirone augmentation of paroxetine in treatment of refractory obsessive-compulsive disorder with depression.
Topics: Antidepressive Agents, Second-Generation; Antipsychotic Agents; Depression; Drug Synergism; Female; Humans; Indoles; Isoindoles; Middle Aged; Obsessive-Compulsive Disorder; Paroxetine; Thiazoles | 2007 |